We have located links that may give you full text access.
Fetal anemia: Determinants and perinatal outcomes according to the method of intrauterine blood transfusion.
Fetal Diagnosis and Therapy 2023 October 10
INTRODUCTION: Fetal anemia from hemolytic disease treated by intrauterine transfusion (IUT) can be performed by intraperitoneal, intracardiac and intravascular transfusion (IVT). Objective of our study was to compare different transfusion techniques.
METHODS: Retrospective review of IUT secondary to red cell alloimmunization at eight international centers from 2012-2020. Severe anemia suspected if middle cerebral artery peak systolic velocity 1.5 MoM. Demographic, delivery and postnatal variables were analyzed.
RESULTS: Total of 344 procedures, 325 IVT and 19 other techniques (non-IVT) included. No difference in demographics, history of stillbirth (20.5 vs 15.8%, p=0.7), prior pregnancy IUT (25.6 vs 31.6%, p=0.5) or neonatal transfusion (36.1 vs 43.8%, p=0.5). At first IUT, non-IVT had higher hydrops (42.1% vs. 20.4%, p=0.03), lower starting hematocrit (13.3% (±6) vs. 17.7% (±8.2), p = 0.04) and trend towards lower gestational age (24.6 (20.1-27) vs. 26.4 (23.2-29.6) weeks, p=0.08). No difference in birthweight, neonatal phototherapy, exchange or simple transfusion.
CONCLUSION: This is one of the largest studies comparing techniques to treat fetal anemia. IVT was most performed, other techniques were more likely performed in hydrops and lower starting hematocrit was seen. Neither technique affected outcomes. This study may suggest that physician's experience may be the strongest contributor of outcomes.
METHODS: Retrospective review of IUT secondary to red cell alloimmunization at eight international centers from 2012-2020. Severe anemia suspected if middle cerebral artery peak systolic velocity 1.5 MoM. Demographic, delivery and postnatal variables were analyzed.
RESULTS: Total of 344 procedures, 325 IVT and 19 other techniques (non-IVT) included. No difference in demographics, history of stillbirth (20.5 vs 15.8%, p=0.7), prior pregnancy IUT (25.6 vs 31.6%, p=0.5) or neonatal transfusion (36.1 vs 43.8%, p=0.5). At first IUT, non-IVT had higher hydrops (42.1% vs. 20.4%, p=0.03), lower starting hematocrit (13.3% (±6) vs. 17.7% (±8.2), p = 0.04) and trend towards lower gestational age (24.6 (20.1-27) vs. 26.4 (23.2-29.6) weeks, p=0.08). No difference in birthweight, neonatal phototherapy, exchange or simple transfusion.
CONCLUSION: This is one of the largest studies comparing techniques to treat fetal anemia. IVT was most performed, other techniques were more likely performed in hydrops and lower starting hematocrit was seen. Neither technique affected outcomes. This study may suggest that physician's experience may be the strongest contributor of outcomes.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app